Prediabetes, often considered the step before diabetes, is when you have higher than usual blood glucose (blood sugar) levels ...

In a phase 1 trial, Novo Nordisk's experimental obesity drug amycretin led to up to 13% weight loss in just three months.

CB1 receptors Skye highlights safety advantages of large-molecule CB1 inhibition compared to small-molecule approach ...

LOTTIE Moss has bravely opened up about her struggles with body image, which at one point saw her go on Ozempic. It’s the ...

Researchers from the University of Liverpool have found that the weight-loss drug tirzepatide could significantly reduce the ...

Skye launched its Phase 2 trial of nimacimab in obesity in August 2024. This trial, which is the first to also assess a GLP-1/CB1 inhibitor combination, is expected to report interim weight loss data ...

Researchers used real-world data to identify key factors for long-term weight loss for patients taking GLP-1 drugs like Ozempic and Wegovy.

Therefore, maintaining or increasing lean muscle mass can help boost the metabolic rate, assisting in more effective and sustained weight loss. In the 28-day DIO study, mice treated with the HT-6184 ...

Located at 150 Pine Forest Drive, Ste. 603, Shenandoah, the practice specializes in weight loss with an emphasis on the use of GLP-1 medications, a class of drugs that help regulate appetite and blood ...

Compounded semaglutide has emerged as a significant development in the management of obesity and type 2 diabetes. As a ...

Prescription weight loss drugs have become so popular in the United States that suppliers have struggled to keep up.

An exciting new Irish study has found that Semaglutide, the substance found in popular weight-loss drugs Ozempic and Wegovy, ...